Genexine, Inc.
Records under this name other than the patents Genexine, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 23 patents it holds.
Showing 1 to 7 of 7 · Back to Genexine, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,001,620 | Composition comprising recombinant human thyroid stimulating hormone and method for producing recombinant human thyroid stimulating hormone Formerly held Lapsed on the fee record Ended May 11, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 11, 2025 | From the USPTO record |
| US RE46,453 | Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer Lapsed on the fee record Ended Mar 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 20, 2024 | From the USPTO record |
| US 7,253,151 | Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant Lapsed on the fee record Ended Aug 7, 2019 · From the USPTO record | Lapsed on the fee record | Ended Aug 7, 2019 | From the USPTO record |
| US 7,910,564 | Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant Lapsed on the fee record Ended Mar 22, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 22, 2019 | From the USPTO record |
| US 8,137,674 | Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer Surrendered on reissue Surrendered on reissue Jun 27, 2017 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Jun 27, 2017 | From the USPTO record |
| US 7,989,425 | Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus Lapsed on the fee record Ended Aug 2, 2015 · From the USPTO record | Lapsed on the fee record | Ended Aug 2, 2015 | From the USPTO record |
| US 6,818,442 | AIDS DNA vaccine that prevents SIVmac239 virus infection in monkeys Lapsed on the fee record Ended Nov 16, 2012 · From the USPTO record | Lapsed on the fee record | Ended Nov 16, 2012 | From the USPTO record |